Scholarlink

Purpose <p>A cancer diagnosis results in significant distress and adverse psychosocial sequelae, including suicide, the 10th leading cause of death in the&#xa0;USA. Primary risks for death by suicide include depression and opioid abuse, which are prevalent among cancer survivors. Yet, it remains unclear whether they are also associated with other suicidal outcomes, such as ideation, planning, and suicidal attempt.</p> Methods <p>We used cross-sectional data from the National Survey on Drug Use and Health (2015–2019, <i>N</i> = 214,271), a nationwide study in the USA that provides data on mental health and other health concerns. Outcome of interest was suicidality (suicidal ideation, planning, and attempt). Main exposures were history of depression and non-medical use of pain prescriptions. Using weighted logistic regression analyses adjusted for sociodemographic factors and substance use, we estimated odds of suicidal ideation, planning, and attempt.</p> Results <p>There were 7635 cancer survivors in our study, which was our analytic sample. We found an associations between a history of cancer and suicidal ideation (aOR = 1.32, 95% CI 1.10, 1.58). Among cancer survivors, depression and non-medical use of pain prescriptions were consistently associated with suicidal ideation (aOR<sub>depression</sub> = 7.37, 95% CI 4.52, 12.03; aOR<sub>pain prescriptions</sub> = 3.36, 95% CI 1.27, 8.91, planning (aOR<sub>depression</sub> = 10.31, 95% CI 5.79, 18.34; and aOR<sub>pain prescriptions</sub> = 3.77, 95% CI 1.20, 11.85), and attempt (aOR<sub>depression</sub> = 4.29, 95% CI 1.41, 13.06).</p> Conclusion <p>Both depression and non-medical pain prescriptions are&#xa0;independently associated with increased odds of suicidal behavior among cancer survivors. Routinely assessing for depression and history of&#xa0;non-medical use of pain prescriptions could be&#xa0;an&#xa0;important suicide prevention strategy in oncology.</p> Implications for Cancer Survivors <p>Given the increased risk of suicide mortality among cancer survivors, it is critical that risk factors for suicidal&#xa0;behavior, such as depression and use of non-medical pain prescriptions, are routinely screened for as part of cancer&#xa0;care.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Depression, non-medical pain prescriptions, and suicidal behavior in cancer survivors

  • 期刊论文

  • 发表日期：

    2025年1月16日

查看全文
  • Judith Mwobobia,
  • Melissa C. White,
  • Oyomoare L. Osazuwa-Peters,
  • Eric Adjei Boakye,
  • Dina K. Abouelella,
  • Justin M. Barnes,
  • Chi T. Viet,
  • Katherine Ramos,
  • Cheyenne Corbett,
  • Nosayaba Osazuwa-Peters

摘要

Purpose

A cancer diagnosis results in significant distress and adverse psychosocial sequelae, including suicide, the 10th leading cause of death in the USA. Primary risks for death by suicide include depression and opioid abuse, which are prevalent among cancer survivors. Yet, it remains unclear whether they are also associated with other suicidal outcomes, such as ideation, planning, and suicidal attempt.

Methods

We used cross-sectional data from the National Survey on Drug Use and Health (2015–2019, N = 214,271), a nationwide study in the USA that provides data on mental health and other health concerns. Outcome of interest was suicidality (suicidal ideation, planning, and attempt). Main exposures were history of depression and non-medical use of pain prescriptions. Using weighted logistic regression analyses adjusted for sociodemographic factors and substance use, we estimated odds of suicidal ideation, planning, and attempt.

Results

There were 7635 cancer survivors in our study, which was our analytic sample. We found an associations between a history of cancer and suicidal ideation (aOR = 1.32, 95% CI 1.10, 1.58). Among cancer survivors, depression and non-medical use of pain prescriptions were consistently associated with suicidal ideation (aORdepression = 7.37, 95% CI 4.52, 12.03; aORpain prescriptions = 3.36, 95% CI 1.27, 8.91, planning (aORdepression = 10.31, 95% CI 5.79, 18.34; and aORpain prescriptions = 3.77, 95% CI 1.20, 11.85), and attempt (aORdepression = 4.29, 95% CI 1.41, 13.06).

Conclusion

Both depression and non-medical pain prescriptions are independently associated with increased odds of suicidal behavior among cancer survivors. Routinely assessing for depression and history of non-medical use of pain prescriptions could be an important suicide prevention strategy in oncology.

Implications for Cancer Survivors

Given the increased risk of suicide mortality among cancer survivors, it is critical that risk factors for suicidal behavior, such as depression and use of non-medical pain prescriptions, are routinely screened for as part of cancer care.